Marta Kutwin Selected Research

Proteins (Proteins, Gene)

11/2023	Influence of C60 Nanofilm on the Expression of Selected Markers of Mesenchymal-Epithelial Transition in Hepatocellular Carcinoma.
5/2023	Effect of Melittin Complexes with Graphene and Graphene Oxide on Triple-Negative Breast Cancer Tumors Grown on Chicken Embryo Chorioallantoic Membrane.
1/2023	Influence of GO-Antisense miRNA-21 on the Expression of Selected Cytokines at Glioblastoma Cell Lines.
12/2019	Influence of Selected Carbon Nanostructures on the CYP2C9 Enzyme of the P450 Cytochrome.
2/2019	Degradation of Mitochondria and Oxidative Stress as the Main Mechanism of Toxicity of Pristine Graphene on U87 Glioblastoma Cells and Tumors and HS-5 Cells.
1/2017	Assessment of the proliferation status of glioblastoma cell and tumour tissue after nanoplatinum treatment.
10/2015	Graphene Functionalized with Arginine Decreases the Development of Glioblastoma Multiforme Tumor in a Gene-Dependent Manner.
1/2015	In vitro and in vivo effects of graphene oxide and reduced graphene oxide on glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marta Kutwin Research Topics

Disease

18	Neoplasms (Cancer) 05/2023 - 01/2014
13	Glioblastoma (Glioblastoma Multiforme) 06/2023 - 01/2014
6	Liver Neoplasms (Liver Cancer) 11/2023 - 01/2016
6	Glioma (Gliomas) 01/2023 - 01/2015
4	Hepatocellular Carcinoma (Hepatoma) 06/2023 - 01/2015
4	Breast Neoplasms (Breast Cancer) 06/2023 - 03/2019
2	Inflammation (Inflammations) 01/2024 - 11/2023
2	Hemolysis 09/2017 - 01/2014
2	Body Weight (Weight, Body) 10/2016 - 12/2015
1	Triple Negative Breast Neoplasms 05/2023
1	Necrosis 12/2019
1	Adenocarcinoma 03/2019
1	Colorectal Neoplasms (Colorectal Cancer) 03/2019
1	Infections 01/2018
1	Brain Neoplasms (Brain Tumor) 10/2017
1	Drug-Related Side Effects and Adverse Reactions 10/2017
1	type 2 alpha 1 Collagenopathy 01/2015

Drug/Important Bio-Agent (IBA)

11	GraphiteIBA 05/2023 - 01/2015
9	graphene oxideIBA 05/2023 - 01/2015
8	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2015
7	DiamondIBA 06/2023 - 01/2015
5	CarbonIBA 12/2019 - 01/2014
3	fullerene C60IBA 11/2023 - 01/2019
3	Messenger RNA (mRNA)IBA 01/2023 - 10/2017
3	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 01/2014
2	Melitten (Melittin)IBA 05/2023 - 12/2019
2	CytokinesIBA 05/2023 - 01/2023
2	PlatinumIBA 03/2019 - 10/2017
2	SilverIBA 01/2018 - 01/2015
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2017 - 01/2017
1	Neutral RedIBA 01/2024
1	hydroxide ionIBA 01/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2023
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2023
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2023
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 09/2021
1	OxidesIBA 12/2019
1	Bee Venoms (Bee Venom)IBA 12/2019
1	Cytochrome P-450 CYP2C9IBA 12/2019
1	CyclinsIBA 04/2019
1	diazonaphthalenedisulfonic acid (NDS)IBA 04/2019
1	EnzymesIBA 03/2019
1	Bromodeoxyuridine (BrdU)IBA 03/2019
1	SaltsIBA 03/2019
1	Caspase 3 (Caspase-3)IBA 10/2017
1	CateninsIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	CurcuminIBA 01/2016
1	Proline (L-Proline)FDA Link 10/2015
1	Arginine (L-Arginine)FDA Link 10/2015
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2015

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2015
2	Aftercare (After-Treatment) 01/2023 - 01/2014
1	Injections 09/2017
1	Intraperitoneal Injections 12/2015